PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Northeastern University School of Pharmacy, Boston, MA.\', \'Massachusetts General Hospital Substance Use Disorders Initiative, Boston, MA, USA.\', \'South Dakota State University College of Pharmacy and Allied Health Professions, Brookings, SD.\', \'University of South Dakota School of Medicine, Vermillion, SD, USA.\', \'Substance Use Disorder Transitions of Care Clinic, Inpatient Psychiatry and Addiction Services, VA Tennessee Valley Healthcare System, Nashville, TN, USA.\', \'University of Southern California School of Pharmacy, Los Angeles, CA, and Los Angeles County Department of Health Services, Los Angeles, CA, USA.\', \'University of Texas at Austin College of Pharmacy, Austin, TX, USA.\', \'University of New England College of Pharmacy, Portland, ME, and Maine Medical Center Consult-Liaison Service, Portland, ME, USA.\', \'Scripps Mercy Hospital, San Diego, CA, USA.\', \'Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, PA, USA.\', \'Chicago Midwestern University, Chicago College of Pharmacy, Downers Grove, IL.\', \'Rush University Medical Center Substance Use Intervention Team, Chicago, IL, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/ajhp/zxab003
?:doi
?:hasPublicationType
?:journal
  • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
is ?:pmid of
?:pmid
?:pmid
  • 33411894
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all